A new delivery particle developed at MIT could make mRNA vaccines more effective and potentially lower the cost per vaccine ...
Cardiovascular disease continues to be the leading cause of death worldwide. But advances in heart-failure therapeutics have ...
The team used the AMG1541 LNP to deliver an mRNA influenza vaccine in mice. They compared this vaccine’s effectiveness to a flu vaccine made with the lipid SM-102, which is FDA-approved and was used ...
News-Medical.Net on MSN
BIOVECTRA and Revolution Biomanufacturing partner to deliver integrated mRNA Design and GMP production services
BIOVECTRA, a part of Agilent Technologies Inc., and Revolution Biomanufacturing Inc. today announced a collaboration that ...
Scientists found that DNA’s phosphate groups can direct chemical reactions to make the correct mirror-image form of drug ...
News Medical on MSN
MIT research finds particles that enhance mRNA delivery could reduce vaccine dosage and costs
A new lipid nanoparticle could make mRNA vaccines more effective and potentially lower the cost per dose. New research suggests an mRNA influenza vaccine delivered with the new particle could generate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback